Phase II study of hyper-CMAD with liposomal vincristine as frontline therapy for patients with acute lymphoblastic leukemia

Publication date: September 2015 Source:Clinical Lymphoma Myeloma and Leukemia, Volume 15, Supplement 2 Author(s): Koji Sasaki, Susan O’Brien, Deborah Thomas, Maria Khouri, Musa Yilmaz, Guillermo Garcia-Manero, Farhad Ravandi, Gautam Borthakur, Rebecca Garris, Evguenia Gachimova, Courtney Dinardo, Naveen Pemmaraju, Jorge Cortes, Hagop Kantarjian, Elias Jabbour
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research